Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBSR vs Escitalopram for Anxiety Disorders (TAME)
NCT03522844Phase 4Completed
- Sponsor
- Georgetown University
- Start
- Jun 2018
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), panic disorder, agoraphobia, sponsored by Georgetown University. Started Jun 2018; status: completed.
02
Drugs
escitalopram
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)panic disorderagoraphobia
Beyond the preview
Go deeper on NCT03522844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03522844.